5 December 2024 - The medication will initially be offered only to those people with the highest clinical needs.
Around a quarter of a million people living with obesity will be offered the weight loss drug tirzepatide, alongside a reduced-calorie diet and increased physical activity, over the next three years, final draft guidance from NICE has outlined.